These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 21976721)

  • 1. The MC4R(I251L) allele is associated with better metabolic status and more weight loss after gastric bypass surgery.
    Mirshahi UL; Still CD; Masker KK; Gerhard GS; Carey DJ; Mirshahi T
    J Clin Endocrinol Metab; 2011 Dec; 96(12):E2088-96. PubMed ID: 21976721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term weight-loss in gastric bypass patients carrying melanocortin 4 receptor variants.
    Moore BS; Mirshahi UL; Yost EA; Stepanchick AN; Bedrin MD; Styer AM; Jackson KK; Still CD; Breitwieser GE; Gerhard GS; Carey DJ; Mirshahi T
    PLoS One; 2014; 9(4):e93629. PubMed ID: 24705671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weight-independent effects of roux-en-Y gastric bypass on glucose homeostasis via melanocortin-4 receptors in mice and humans.
    Zechner JF; Mirshahi UL; Satapati S; Berglund ED; Rossi J; Scott MM; Still CD; Gerhard GS; Burgess SC; Mirshahi T; Aguirre V
    Gastroenterology; 2013 Mar; 144(3):580-590.e7. PubMed ID: 23159449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse models for V103I and I251L gain of function variants of the human MC4R display decreased adiposity but are not protected against a hypercaloric diet.
    Rojo D; McCarthy C; Raingo J; Rubinstein M
    Mol Metab; 2020 Dec; 42():101077. PubMed ID: 32916307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanocortin-4 receptor signaling is required for weight loss after gastric bypass surgery.
    Hatoum IJ; Stylopoulos N; Vanhoose AM; Boyd KL; Yin DP; Ellacott KL; Ma LL; Blaszczyk K; Keogh JM; Cone RD; Farooqi IS; Kaplan LM
    J Clin Endocrinol Metab; 2012 Jun; 97(6):E1023-31. PubMed ID: 22492873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weight loss after Roux-en-Y gastric bypass in obese patients heterozygous for MC4R mutations.
    Aslan IR; Campos GM; Calton MA; Evans DS; Merriman RB; Vaisse C
    Obes Surg; 2011 Jul; 21(7):930-4. PubMed ID: 20957447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanocortin-4 receptor mutations and polymorphisms do not affect weight loss after bariatric surgery.
    Valette M; Poitou C; Le Beyec J; Bouillot JL; Clement K; Czernichow S
    PLoS One; 2012; 7(11):e48221. PubMed ID: 23185251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the Melanocortin 4-Receptor Ile269Asn Mutation on Weight Loss Response to Dietary, Phentermine and Bariatric Surgery Interventions.
    Salazar-Valencia IG; Villamil-Ramírez H; Barajas-Olmos F; Guevara-Cruz M; Macias-Kauffer LR; García-Ortiz H; Hernández-Vergara O; Díaz de Sandy-Galán DA; León-Mimila P; Centeno-Cruz F; González-Salazar LE; Guizar-Heredia R; Pichardo-Ontiveros E; Jacobo-Albavera L; Posadas-Sánchez R; Vargas-Alarcón G; Velazquez-Cruz R; Gutiérrez-Aguilar R; Zerrweck C; Rocha-González HI; Reyes-García JG; Carrasco-Portugal MDC; Flores-Murrieta FJ; Tovar AR; Orozco L; Villarreal-Molina T; Canizales-Quinteros S
    Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Weight Outcome After Bariatric Surgery in Patients with Melanocortin-4 Receptor Gene Variants: a Case-Control Study of 105 Patients.
    Cooiman MI; Alsters SIM; Duquesnoy M; Hazebroek EJ; Meijers-Heijboer HJ; Chahal H; Le Beyec-Le Bihan J; Clément K; Soula H; Blakemore AI; Poitou C; van Haelst MM
    Obes Surg; 2022 Mar; 32(3):837-844. PubMed ID: 34984630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High allelic burden of four obesity SNPs is associated with poorer weight loss outcomes following gastric bypass surgery.
    Still CD; Wood GC; Chu X; Erdman R; Manney CH; Benotti PN; Petrick AT; Strodel WE; Mirshahi UL; Mirshahi T; Carey DJ; Gerhard GS
    Obesity (Silver Spring); 2011 Aug; 19(8):1676-83. PubMed ID: 21311511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Heterozygous Variants in the Leptin-Melanocortin Pathway on Roux-en-Y Gastric Bypass Outcomes: a 15-Year Case-Control Study.
    Campos A; Cifuentes L; Hashem A; Busebee B; Hurtado-Andrade MD; Ricardo-Silgado ML; McRae A; De la Rosa A; Feris F; Bublitz JT; Hensrud D; Camilleri M; Kellogg TA; Eckel-Passow JE; Olson J; Acosta A
    Obes Surg; 2022 Aug; 32(8):2632-2640. PubMed ID: 35654930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Farnesoid X receptor contributes to body weight-independent improvements in glycemic control after Roux-en-Y gastric bypass surgery in diet-induced obese mice.
    Li K; Zou J; Li S; Guo J; Shi W; Wang B; Han X; Zhang H; Zhang P; Miao Z; Li Y
    Mol Metab; 2020 Jul; 37():100980. PubMed ID: 32305491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five-year outcome of bariatric surgery in a patient with melanocortin-4 receptor mutation.
    Elkhenini HF; New JP; Syed AA
    Clin Obes; 2014 Apr; 4(2):121-4. PubMed ID: 25826735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene variants and binge eating as predictors of comorbidity and outcome of treatment in severe obesity.
    Potoczna N; Branson R; Kral JG; Piec G; Steffen R; Ricklin T; Hoehe MR; Lentes KU; Horber FF
    J Gastrointest Surg; 2004 Dec; 8(8):971-81; discussion 981-2. PubMed ID: 15585384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanocortin 4 receptor mutations in obese Czech children: studies of prevalence, phenotype development, weight reduction response, and functional analysis.
    Hainerová I; Larsen LH; Holst B; Finková M; Hainer V; Lebl J; Hansen T; Pedersen O
    J Clin Endocrinol Metab; 2007 Sep; 92(9):3689-96. PubMed ID: 17579204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calorie restriction is a major determinant of the short-term metabolic effects of gastric bypass surgery in obese type 2 diabetic patients.
    Lips MA; de Groot GH; van Klinken JB; Aarts E; Berends FJ; Janssen IM; Van Ramshorst B; Van Wagensveld BA; Swank DJ; Van Dielen F; Willems van Dijk K; Pijl H
    Clin Endocrinol (Oxf); 2014 Jun; 80(6):834-42. PubMed ID: 23711328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary Protein Modifies the Effect of the
    Huang T; Zheng Y; Hruby A; Williamson DA; Bray GA; Shen Y; Sacks FM; Qi L
    J Nutr; 2017 Mar; 147(3):439-444. PubMed ID: 28148682
    [No Abstract]   [Full Text] [Related]  

  • 18. The Role of FTO and Vitamin D for the Weight Loss Effect of Roux-en-Y Gastric Bypass Surgery in Obese Patients.
    Bandstein M; Schultes B; Ernst B; Thurnheer M; Schiöth HB; Benedict C
    Obes Surg; 2015 Nov; 25(11):2071-7. PubMed ID: 25724814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose Metabolism After Gastric Banding and Gastric Bypass in Individuals With Type 2 Diabetes: Weight Loss Effect.
    Holter MM; Dutia R; Stano SM; Prigeon RL; Homel P; McGinty JJ; Belsley SJ; Ren CJ; Rosen D; Laferrère B
    Diabetes Care; 2017 Jan; 40(1):7-15. PubMed ID: 27999001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional Characterization of MC4R Variants in Chinese Morbid Obese Patients and Weight Loss after Bariatric Surgery.
    Gong Y; Wu Q; Huang S; Fu Z; Ye J; Liu R; Lin S; Guan W; Yang N; Li JZ; Liang H; Zhou H
    Adv Biol (Weinh); 2023 Sep; 7(9):e2300007. PubMed ID: 37140139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.